tosufloxacin has been researched along with Bacterial Disease in 14 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method." | 9.07 | [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. ( Hirano, A; Ikeuchi, T; Kawamura, N; Onodera, S; Osada, T; Satomi, Y; Suzuki, K; Yamamoto, Y; Yoshimura, S, 1993) |
| "To objectively assess azithromycin (AZM) for its clinical efficacy, safety and usefulness in the treatment of acute odontogenic infections (periodontitis, pericoronitis and osteitis of the jaw), a double-blind, randomized, multi-center trial was conducted in which tosufloxacin tosilate (TFLX) was used as the control drug." | 5.08 | [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. ( Kaneko, A; Karakida, K; Katoh, H; Naitoh, H; Sakamoto, H; Sasaki, J; Shiiki, K; Tomita, F; Yamane, N; Yoshida, H, 1995) |
| "In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method." | 5.07 | [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. ( Hirano, A; Ikeuchi, T; Kawamura, N; Onodera, S; Osada, T; Satomi, Y; Suzuki, K; Yamamoto, Y; Yoshimura, S, 1993) |
| "Tosufloxacin was as effective as levofloxacin when administered twice daily for 2 days as prophylaxis for TBP, which suggests that this regimen is useful for reducing the clinical and febrile infection rate following TBP." | 2.73 | Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. ( Ishitoya, S; Kamoto, T; Ogawa, O; Okumura, K; Segawa, T; Yamamoto, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosen, T | 1 |
| Chu, DT | 1 |
| Lico, IM | 1 |
| Fernandes, PB | 1 |
| Marsh, K | 1 |
| Shen, L | 1 |
| Cepa, VG | 1 |
| Pernet, AG | 1 |
| Sunakawa, K | 1 |
| Onai, K | 1 |
| Yamazaki, T | 1 |
| Sasaki, J | 2 |
| Yamamoto, S | 1 |
| Ishitoya, S | 1 |
| Segawa, T | 1 |
| Kamoto, T | 1 |
| Okumura, K | 1 |
| Ogawa, O | 1 |
| Kaneko, A | 1 |
| Karakida, K | 1 |
| Shiiki, K | 1 |
| Sakamoto, H | 1 |
| Naitoh, H | 1 |
| Yamane, N | 1 |
| Tomita, F | 1 |
| Katoh, H | 1 |
| Yoshida, H | 1 |
| Mori, S | 1 |
| Ohashi, K | 1 |
| Akiyama, H | 1 |
| Shoji, H | 1 |
| Sato, H | 1 |
| Tanikawa, S | 1 |
| Sakamaki, H | 1 |
| Onozawa, Y | 1 |
| Ikeuchi, T | 1 |
| Kawamura, N | 1 |
| Suzuki, K | 1 |
| Onodera, S | 1 |
| Osada, T | 1 |
| Hirano, A | 1 |
| Satomi, Y | 1 |
| Yoshimura, S | 1 |
| Yamamoto, Y | 1 |
| Fukuoka, Y | 1 |
| Ikeda, Y | 1 |
| Yamashiro, Y | 1 |
| Takahata, M | 1 |
| Todo, Y | 1 |
| Narita, H | 1 |
| Masuda, N | 1 |
| Takahashi, Y | 1 |
| Otsuki, M | 1 |
| Ibuki, E | 1 |
| Miyoshi, H | 1 |
| Nishino, T | 1 |
| Koga, H | 1 |
| Aoyagi, K | 1 |
| Yoshimura, R | 1 |
| Kimura, Y | 1 |
| Iida, M | 1 |
| Fujishima, M | 1 |
| Nord, CE | 1 |
| Edlund, C | 1 |
| Shimada, K | 1 |
| Aoki, T | 1 |
| Matsubara, Y | 1 |
| Sagara, H | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Nitta, Y | 1 |
| Seo, T | 1 |
| Kamimura, M | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Fujimaki, K | 1 |
| Noumi, T | 1 |
| Saikawa, I | 1 |
| Inoue, M | 1 |
| Mitsuhashi, S | 1 |
2 reviews available for tosufloxacin and Bacterial Disease
| Article | Year |
|---|---|
[Azithromycin in dentistry and oral surgery].
Topics: Anti-Infective Agents; Azithromycin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Doubl | 2000 |
[Tosufloxacin tosilate].
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Micro | 1990 |
5 trials available for tosufloxacin and Bacterial Disease
| Article | Year |
|---|---|
Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Cystitis; Fluoroq | 2008 |
[Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Azithromyc | 1995 |
Tosulfloxacin versus norfloxacin for prevention of infections in chemotherapy-induced neutropenic patients.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacterial Infections; Drug Ev | 1994 |
[Clinical studies of tosufloxacin on chronic bacterial prostatitis].
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Dru | 1993 |
[Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
Topics: 4-Quinolones; Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Inf | 1989 |
7 other studies available for tosufloxacin and Bacterial Disease
| Article | Year |
|---|---|
Design, synthesis, and properties of (4S)-7-(4-amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic acids.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Dogs; Fluoroqui | 1988 |
[Intractable pediatric infectious disease: examining the ability of a new drug, tosufloxacin tosilate hydrate for pediatric (discussion)].
Topics: Administration, Oral; Age Factors; Anti-Bacterial Agents; Bacterial Infections; Child; Fluoroquinolo | 2011 |
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases | 1993 |
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; F | 1996 |
Can quinolones cause hemorrhagic colitis of late onset? Report of three cases.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Colitis; Colonoscopy; Enoxacin; F | 1999 |
Efficacy of tosufloxacin in the treatment of experimentally induced intra-abdominal infections in rats.
Topics: 4-Quinolones; Abscess; Animals; Anti-Infective Agents; Bacterial Infections; Disease Models, Animal; | 1992 |
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Escheric | 1988 |